Ethical Considerations in End-of-life Care in the Face of Clinical Futility

Joseph S. Kass, Ariane Lewis, Michael Rubin

Research output: Contribution to journalArticle

Abstract

Management of patients with terminal brain disorders can be medically, socially, and ethically complex. Although a growing number of feasible treatment options may exist, there are times when further treatment can no longer meaningfully improve either quality or length of life. Clinicians and patients should discuss goals of care while patients are capable of making their own decisions. However, because such discussions can be challenging, they are often postponed. These discussions are then conducted with patients' health care proxies after patients lose the capacity to make their own decisions. Disagreements may arise when a patient's surrogate desires continued aggressive interventions that are either biologically futile (incapable of producing the intended physiologic result) or potentially inappropriate (potentially capable of producing the patient's intended effect but in conflict with the medical team's ethical principles). This article explores best practices in addressing these types of conflicts in the critical care unit, but these concepts also broadly apply to other sites of care.

Original languageEnglish (US)
Pages (from-to)1789-1793
Number of pages5
JournalCONTINUUM Lifelong Learning in Neurology
Volume24
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Medical Futility
Terminal Care
Patient Care Planning
Brain Diseases
Proxy
Critical Care
Practice Guidelines
Patient Care
Delivery of Health Care
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Ethical Considerations in End-of-life Care in the Face of Clinical Futility. / Kass, Joseph S.; Lewis, Ariane; Rubin, Michael.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 24, No. 6, 01.12.2018, p. 1789-1793.

Research output: Contribution to journalArticle

@article{f394b38fa26544f2818151d97f1249b6,
title = "Ethical Considerations in End-of-life Care in the Face of Clinical Futility",
abstract = "Management of patients with terminal brain disorders can be medically, socially, and ethically complex. Although a growing number of feasible treatment options may exist, there are times when further treatment can no longer meaningfully improve either quality or length of life. Clinicians and patients should discuss goals of care while patients are capable of making their own decisions. However, because such discussions can be challenging, they are often postponed. These discussions are then conducted with patients' health care proxies after patients lose the capacity to make their own decisions. Disagreements may arise when a patient's surrogate desires continued aggressive interventions that are either biologically futile (incapable of producing the intended physiologic result) or potentially inappropriate (potentially capable of producing the patient's intended effect but in conflict with the medical team's ethical principles). This article explores best practices in addressing these types of conflicts in the critical care unit, but these concepts also broadly apply to other sites of care.",
author = "Kass, {Joseph S.} and Ariane Lewis and Michael Rubin",
year = "2018",
month = "12",
day = "1",
doi = "10.1212/CON.0000000000000680",
language = "English (US)",
volume = "24",
pages = "1789--1793",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Ethical Considerations in End-of-life Care in the Face of Clinical Futility

AU - Kass, Joseph S.

AU - Lewis, Ariane

AU - Rubin, Michael

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Management of patients with terminal brain disorders can be medically, socially, and ethically complex. Although a growing number of feasible treatment options may exist, there are times when further treatment can no longer meaningfully improve either quality or length of life. Clinicians and patients should discuss goals of care while patients are capable of making their own decisions. However, because such discussions can be challenging, they are often postponed. These discussions are then conducted with patients' health care proxies after patients lose the capacity to make their own decisions. Disagreements may arise when a patient's surrogate desires continued aggressive interventions that are either biologically futile (incapable of producing the intended physiologic result) or potentially inappropriate (potentially capable of producing the patient's intended effect but in conflict with the medical team's ethical principles). This article explores best practices in addressing these types of conflicts in the critical care unit, but these concepts also broadly apply to other sites of care.

AB - Management of patients with terminal brain disorders can be medically, socially, and ethically complex. Although a growing number of feasible treatment options may exist, there are times when further treatment can no longer meaningfully improve either quality or length of life. Clinicians and patients should discuss goals of care while patients are capable of making their own decisions. However, because such discussions can be challenging, they are often postponed. These discussions are then conducted with patients' health care proxies after patients lose the capacity to make their own decisions. Disagreements may arise when a patient's surrogate desires continued aggressive interventions that are either biologically futile (incapable of producing the intended physiologic result) or potentially inappropriate (potentially capable of producing the patient's intended effect but in conflict with the medical team's ethical principles). This article explores best practices in addressing these types of conflicts in the critical care unit, but these concepts also broadly apply to other sites of care.

UR - http://www.scopus.com/inward/record.url?scp=85059560139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059560139&partnerID=8YFLogxK

U2 - 10.1212/CON.0000000000000680

DO - 10.1212/CON.0000000000000680

M3 - Article

C2 - 30516606

AN - SCOPUS:85059560139

VL - 24

SP - 1789

EP - 1793

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 6

ER -